Back to top
more

Labcorp (LH)

(Delayed Data from NYSE)

$234.38 USD

234.38
566,922

+5.27 (2.30%)

Updated Nov 6, 2024 04:00 PM ET

After-Market: $234.35 -0.03 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (78 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

CVS Health (CVS) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

CVS Health's (CVS) digital capabilities are expected to have driven consumer engagement across all CVS Health businesses in Q4.

STERIS (STE) to Report Q3 Earnings: What's in the Cards?

by Zacks Equity Research

STERIS' (STE) hospital capital spending is expected to have remained robust in Q3, as evident from the healthcare backlog's recent trend.

Zimmer Biomet (ZBH) to Report Q4 Earnings: What's in Store?

by Zacks Equity Research

Zimmer Biomet (ZBH) is expected to have witnessed continued recovery in its legacy business in the fourth quarter, despite the choppy market situation.

Abbott's (ABT) Q4 Earnings Beat Estimates, Margins Down

by Zacks Equity Research

The downside can be attributed to a manufacturing disruption during 2022 of certain infant formula products at Abbott's (ABT) Sturgis, MI facility.

Quest Diagnostics (DGX) to Report Q4 Earnings: What's in Store?

by Zacks Equity Research

Quest Diagnostics (DGX) ramps up investments to accelerate growth in the base business, particularly in advanced diagnostics and direct-to-consumer testing.

What's in Store for Thermo Fisher (TMO) in Q4 Earnings?

by Zacks Equity Research

The industrywide trend of record-level inflation, supply issues and staffing shortages are expected to have deterred growth in several areas of Thermo Fisher's (TMO) business in Q4.

IDEXX (IDXX) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

IDEXX's (IDXX) CAG premium instrument placements are expected to have recorded significant growth in Q4 owing to continued rise in Catalyst and premium hematology placements.

Non-COVID Diagnostics Sales to Aid Hologic (HOLX) Q1 Earnings

by Zacks Equity Research

The growing adoption of Panther instruments worldwide will likely drive Hologic's (HOLX) Q1 revenues.

Will Boston Scientific (BSX) Beat Q4 Earnings Estimates?

by Zacks Equity Research

Boston Scientific (BSX) is expected to have registered strong growth in EMEA within structural heart, including TAVR, WATCHMAN, and other interventional cardiology therapies.

Here's Why You Should Retain DENTSPLY SIRONA (XRAY) Stock Now

by Zacks Equity Research

DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, macroeconomic factors like weakened global demand, rising costs and forex woes persist.

Align Technology (ALGN) to Post Q4 Earnings: What's in Store?

by Zacks Equity Research

Align Technology's (ALGN) increased shipments in Invisalign case volumes across almost all markets are likely to benefit Q4 revenues.

Reasons to Add Merit Medical (MMSI) Stock to Your Portfolio

by Zacks Equity Research

Investors continue to be optimistic about Merit Medical (MMSI), owing to its strong product portfolio.

Here's Why You Should Retain Intuitive Surgical (ISRG) Stock

by Zacks Equity Research

Intuitive Surgical (ISRG) continues to gain traction from the increasing adoption of the da Vinci Surgical System. Improving margins buoy optimism.

What's in Store for Abbott Laboratories (ABT) in Q4 Earnings?

by Zacks Equity Research

Within Abbott's (ABT) Established Pharmaceuticals Division (EPD), new product launches across key markets have been majorly boosting business in recent months.

Hologic (HOLX) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research

Growing adoption of Panther instruments and growth in the Surgical business will likely drive Hologic's (HOLX) Q1 revenues.

Is Laboratory Corp. of America (LH) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing Cardinal Health (CAH) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

LabCorp (LH) Oncology Arm Gains Traction, Margin Pressure Stays

by Zacks Equity Research

In terms of portfolio enhancement, LabCorp (LH) enters into a collaboration with Becton, Dickinson and Company to advance in life-changing treatments for cancer and other diseases.

Are Options Traders Betting on a Big Move in Laboratory Corporation of America (LH) Stock?

by Zacks Equity Research

Investors need to pay close attention to Laboratory Corporation of America (LH) stock based on the movements in the options market lately.

LabCorp (LH) Gains on Innovation Amid Currency Headwinds

by Zacks Equity Research

LabCorp (LH) enters into a collaboration with Becton, Dickinson and Company to help match patients with critical and potentially life-changing treatments for cancer and other diseases.

Here's Why Investors Should Retain LabCorp (LH) Stock for Now

by Zacks Equity Research

Investors are optimistic about LabCorp (LH), led by strength in its Drug Development business.

LabCorp's (LH) New APH Lab to Expand Global Capabilities

by Zacks Equity Research

LabCorp's (LH) new laboratory is likely to advance clinical trials across therapeutic areas like oncology, hemato-oncology and liver diseases.

The Zacks Analyst Blog Highlights The Home Depot, Diageo, Enbridge, eBay, and Laboratory Corporation of America

by Zacks Equity Research

The Home Depot, Diageo, Enbridge, eBay, and Laboratory Corporation of America are included in this Analyst Blog.

Sheraz Mian headshot

Top Analyst Reports for Home Depot, Diageo & Enbridge

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including The Home Depot, Inc. (HD), Diageo plc (DEO) and Enbridge Inc. (ENB).

LabCorp (LH) Misses Q3 Earnings Estimates, Updates Guidance

by Zacks Equity Research

LabCorp's (LH) organic revenues decline significantly, mainly due to major decrease in COVID-19 PCR and antibody testing sales.